Transcat

Transcat, Inc. is a leading provider of accredited calibration, repair, inspection and compliance services including analytical instrument qualifications, equipment and process validation. Targeted industries include life science, biotechnology, medical device, pharmaceutical and other FDA-regulated industries, industrial manufacturing, energy and utilities, chemical manufacturing and other industries. Throughout its 20 strategically located centers of excellence in the United States, Canada and Puerto Rico, Transcat delivers precise services with reliable turn-around times. The breadth and depth of measurement parameters addressed by Transcat’s ISO/IEC 17025 scopes of accreditation are believed to be among the best in the industry. In addition, Transcat operates as a leading distributor of professional grade handheld test, measurement and control instrumentation. Through its distribution products segment, Transcat markets and distributes premier and propriety brand instruments to nearly 15,000 customers. The Company offers access to more than 25,000 test, measurement and control products. Transcat’s growth strategy is to expand its service and distribution platform comprised of a balanced suite of test products and analytical, calibration, compliance, and validation services. The goal is to deliver specialized technical services with a quality assurance approach, which maximizes document accuracy and on-time job delivery. Transcat answers the call with cGMP, GLP, and GXP compliant services. Transcat can provide life science companies with a reliable alternative service and product solution to the OEMs and to the “generalist” service providers who cannot meet the client’s specialized needs.
Company Growth (employees)
Type
Public
HQ
Rochester, US
Founded
1964
Size (employees)
585 (est)+9%
Transcat was founded in 1964 and is headquartered in Rochester, US

Transcat Office Locations

Transcat has an office in Rochester
Rochester, US (HQ)
35 Vantage Point Dr

Transcat Data and Metrics

Transcat Financial Metrics

Transcat's revenue was reported to be $143.9 m in FY, 2017
USD

Revenue (FY, 2017)

143.9 m

Revenue growth (FY, 2016 - FY, 2017), %

18%

Gross profit (FY, 2017)

35 m

Gross profit margin (FY, 2017), %

24%

Net income (FY, 2017)

4.5 m

EBIT (FY, 2017)

7.9 m

Market capitalization (18-Aug-2017)

92.9 m

Cash (25-Mar-2017)

842 k

EV

119.4 m
Transcat's current market capitalization is $92.9 m.
USDFY, 2014FY, 2015FY, 2016FY, 2017

Revenue

118.5 m123.6 m122.2 m143.9 m

Revenue growth, %

4%(1%)18%

Cost of goods sold

94.5 m93 m108.9 m

Gross profit

29.1 m29.1 m35 m

Gross profit Margin, %

24%24%24%

General and administrative expense

10.5 m

Operating expense total

23.1 m22.3 m22.8 m27 m

EBIT

6.7 m6.8 m6.3 m7.9 m

EBIT margin, %

6%5%5%6%

Pre tax profit

6.4 m6 m7.2 m

Income tax expense

2.4 m1.9 m2.6 m

Net Income

4 m4 m4.1 m4.5 m
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016

Revenue

29.7 m29.5 m30.2 m33.1 m34.5 m37.8 m

Cost of goods sold

22.6 m22.7 m23.4 m24.9 m26.5 m28.9 m

Gross profit

7.1 m6.7 m6.8 m8.2 m8 m8.9 m

Gross profit Margin, %

24%23%22%25%23%24%

EBIT

1 m1.4 m1.7 m1.4 m1.6 m2.4 m

EBIT margin, %

3%5%6%4%5%6%

Pre tax profit

932 k1.3 m1.6 m1.3 m1.4 m2.2 m

Net Income

445 k1.3 m2.1 m601 k1.5 m2.5 m834 k1.7 m3 m
USDFY, 2014FY, 2015FY, 2016FY, 2017

Cash

23 k65 k641 k842 k

Accounts Receivable

1.1 m1.2 m881 k1.2 m

Inventories

1.2 m1.2 m1.1 m10.3 m

Current Assets

25.5 m27.1 m26.2 m35.6 m

PP&E

7.1 m9.4 m12.3 m15.6 m

Goodwill

17.4 m20.9 m29.1 m32.5 m

Total Assets

53.9 m62.1 m76.7 m92.1 m

Accounts Payable

7.1 m7.7 m8.1 m11.6 m

Total Debt

27.3 m

Current Liabilities

13.9 m11.9 m15.8 m19.8 m

Total Liabilities

48.7 m

Additional Paid-in Capital

11.4 m12.3 m13 m13 m

Retained Earnings

14.8 m18.8 m22.8 m27.3 m

Total Equity

30.1 m34.3 m38.9 m43.4 m

Debt to Equity Ratio

0.6 x

Debt to Assets Ratio

0.3 x

Financial Leverage

1.8 x1.8 x2 x2.1 x
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016

Cash

50 k163 k152 k781 k598 k559 k

Accounts Receivable

776 k1.4 m1.2 m934 k1.5 m1.8 m

Inventories

6.6 m6.3 m5.8 m7.6 m7.5 m10.8 m

Current Assets

24.1 m25.2 m24.3 m27.8 m28.8 m34.3 m

PP&E

10 m11.4 m11.8 m14 m14.7 m15.4 m

Goodwill

21.7 m22.7 m22.5 m32.7 m32.7 m32.4 m

Total Assets

60.7 m64.4 m63.5 m85.2 m86 m91.3 m

Accounts Payable

6.5 m8.4 m8.8 m7.3 m10.4 m11.9 m

Current Liabilities

10.4 m12.8 m12.2 m16.2 m19.6 m20.9 m

Additional Paid-in Capital

12.5 m12.8 m12.8 m13.2 m13.5 m13.5 m

Retained Earnings

19.3 m20.2 m21.2 m23.6 m24.5 m25.8 m

Total Equity

35.2 m36 m37 m40.1 m41.2 m42.4 m

Financial Leverage

1.7 x1.8 x1.7 x2.1 x2.1 x2.2 x
USDFY, 2014FY, 2015FY, 2016FY, 2017

Net Income

4 m4 m4.1 m4.5 m

Depreciation and Amortization

2.9 m3.1 m3.9 m6.2 m

Inventories

681 k(593 k)177 k(3.4 m)

Accounts Payable

(1.8 m)464 k446 k3.1 m

Cash From Operating Activities

(383 k)42 k576 k7.5 m

Purchases of PP&E

(2 m)(3.5 m)(5.3 m)

Cash From Investing Activities

(1.7 m)(10.7 m)(18 m)(12.2 m)

Cash From Financing Activities

(6.6 m)5 m7.2 m4.8 m

Interest Paid

121 k232 k243 k686 k
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016

Net Income

445 k1.3 m2.1 m601 k1.5 m2.5 m834 k1.7 m3 m

Depreciation and Amortization

624 k1.4 m2.3 m840 k1.7 m2.7 m1.5 m3.1 m4.7 m

Inventories

(2 m)(1.3 m)(1.1 m)161 k459 k914 k(815 k)(735 k)(4 m)

Accounts Payable

182 k1 m77 k(1.2 m)(309 k)(271 k)(1.2 m)1.9 m3.4 m

Cash From Operating Activities

(2.4 m)(411 k)1.2 m2.6 m5.3 m7.4 m(140 k)5 m3.9 m

Purchases of PP&E

(711 k)(1.9 m)(2.7 m)(1.1 m)(2.5 m)(4.1 m)

Cash From Investing Activities

(703 k)(8.5 m)(9.3 m)(1.8 m)(5.6 m)(6.6 m)(7.9 m)(9.5 m)(11.1 m)

Cash From Financing Activities

3.4 m9 m7.6 m(657 k)(21 k)(1.4 m)8.4 m4.5 m6.9 m

Interest Paid

37 k71 k145 k54 k101 k155 k192 k289 k488 k
USDY, 2017

EV/EBIT

15 x

EV/CFO

15.8 x

Revenue/Employee

256.5 k

Debt/Equity

0.6 x

Debt/Assets

0.3 x

Financial Leverage

2.1 x

Transcat Market Value History

Traffic Overview of Transcat

Transcat Online and Social Media Presence

Transcat News and Updates

NaviGate Cardiac Structures Inc. (“NCSI”) Reports World’s First Transcatheter Tricuspid Valved Stent is Successfully Implanted

PRESS RELEASE: NaviGate Cardiac Structures Inc. ("NCSI") announced today that a novel valved stent that can capture the enlarged annulus in patients suffering from functional tricuspid regurgitation (FTR) was implanted in a patient presenting...

Transcat Company Life and Culture

You may also be interested in